Gastrointestinal Manifestations of Coronavirus Disease 2019 across the United States: A Multi-Center Cohort Study

By sjmartinez • July 19, 2022

Patel AP, Sanders TK, Prakash P, Law J, Alvencar S, Choi A, Shah J, Patel K, Srivoleti P, Chauhan K, Weissman S, Holzwanger E, Dhingra R, Nguyen M, Kim D, Sidhu T, Stallwood C, Dickstein A, Parekh N, Altayar O, Ciorba MA, Yu J, Chen LA, Tabibian JH, Limketkai BN. Gastrointestinal Manifestations of Coronavirus Disease 2019 across the United States: A Multi-Center Cohort Study. Gastro Hep Adv. 2022 Jul 19. doi: 10.1016/j.gastha.2022.07.002. Epub ahead of print. PMID: 35874930; PMCID: PMC9293374.

Tags: acquired immunodeficiency syndrome, adjusted odds ratio, AIDS, alanine aminotransferase, ALT, analysis of variance, ANOVA, aOR, aspartate aminotransferase, AST, BMI, body mass index, CI, confidence interval, coronavirus disease 2019, covid-19, Digestive Diseases, gastrointestinal, GI, HIV, human immunodeficiency virus, ICU, Institutional Review Board, Intensive Care Unit, IRB, odds ratio, OR, Publications, SARS-CoV-2, SD, standard deviation, UCLA, United States, University of California Los Angeles, US, WHO, World Health Organization

Distinct risk groups with different healthcare barriers and acute care use exist in the U.S. population with chronic liver disease

Wong CR, Crespi CM, Glenn B, Han SB, Macinko JA, Bastani R. Distinct risk groups with different healthcare barriers and acute care use exist in[...]

Trypsin in pancreatitis: The culprit, a mediator, or epiphenomenon?

Gukovskaya AS, Lerch MM, Mayerle J, Sendler M, Ji B, Saluja AK, Gorelick FS, Gukovsky I. Trypsin in pancreatitis: The culprit, a mediator, or epiphenomenon?[...]

Stricturing Crohn’s Disease: When Biologics May Help or Not?

Fansiwala K, Limketkai BN. Stricturing Crohn's Disease: When Biologics May Help or Not? Inflamm Bowel Dis. 2024 Nov 12:izae264. doi: 10.1093/ibd/izae264. Epub ahead of print.[...]